Madrona Pharmaceuticals, Inc
Exclusive US provider of only pharma-grade, IP-protected chewable softgel dosage technology that improves common medications’ convenience & palatability.
- Stage Prototype Ready
- Industry Consumer Products
- Location Seattle, WA, USA
- Currency USD
- Founded June 2017
- Employees 5
- Incorporation Type C-corp
- Website madronapharma.com
Company Summary
Madrona Pharmaceuticals is the exclusive US provider of the only pharmaceutical-grade, IP-protected chewable softgel dosage technology designed to improve consumer experience by offering better taste, convenience, palatability and safety to both large-market and niche medications.
Team
-
CEOOver two decades of leadership experience in pharmaceutical product development & disease program management at WHO and Bill & Melinda Gates Foundation.
-
Chief Strategy OfficerTen years of professional experience. MBA candidate, start-up and small business strategy consultant, business developer, and former Boeing design and certification engineer with significant skill-set in FAA and FDA compliance strategy.
-
Chief Branding & Engagement OfficerOver two decades international experience as senior communications consultant & marketing, branding and engagement leader for firms such as ZyLAB, Monsanto, Blackhawk, and TerraSource Global.
-
Chief Operating OfficerEntrepreneurial operations leader with global experience in science-based industries, ranging from scrappy start-ups to Big Pharma. With a foundation in engineering and business, her focus has been in the strategic planning, development, and launch of products and programs.
-
Jim MariniChief Marketing and Sales OfficerPrincipal, JDM Associates. 25+ years experience in sales, operations, & executive leadership in consumer healthcare (Zicam(R) launch) and start-ups.
Advisors
-
Jean-Pierre (JP) MillonUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.